Showing 1 posts of 1 posts found.
Sanofi has launched its inhalable insulin Afrezza in the US to control blood sugar in people with type 1 and …
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection
Coriolis Pharma appoints Teun van der Heide as CEO
NEC joins €6.5m European project using AI for pandemic vaccine design
The evidence bar impacting UK medical cannabis access